Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers
نویسندگان
چکیده
منابع مشابه
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
The new WHO classification of gastroenteropancreatic (GEP) neuroendocrine tumors (NET) implies that G3 neoplasms with mitotic index >20 and/or Ki67 index >20% are neuroendocrine carcinomas (NEC), described as poorly differentiated, small or large cell types, by analogy with lung NEC. To characterize the subgroup of non-small-cell-type GEP and thoracic NET with mitotic index >20 and/or Ki67 >20%...
متن کاملTherapeutic Strategies in Ovarian Cancer
Therapeutic management for ovarian cancer (OC) requires effective treatment methods such as optimization in terms of technical variability, dosage, or administration period and the introduction of new therapeutic methods in the existing protocols, all in order to improve immediate results, especially of the long term. Establishing therapeutic strategies are based on the main factors that influe...
متن کاملTherapeutic strategies in colonic cancer.
Colonic cancer is the most common malignancy of the digestive tract, representing 13% of all malignancies. The aim of the study is to evaluate the current therapeutic strategy in patients with CC. Mortality from the disease is declining in many Western countries; this may be the result of screening for CC, resection of adenomas, early detection of tumoral lesions and the use of individualized t...
متن کاملGastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality
We read with great interest the excellent article by Coriat et al. titled “Gastroenteropancreatic on Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement,” published in The Oncologist [1]. The authors reviewed in detail the epidemiology and made recommendations for the management of this new entity. They concluded that Gastroenteropancreatic (GEP) Neuroendocrine Tumo...
متن کاملCharacteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
Data on gastroenteropancreatic neuroendocrine neoplasms (NEN) G3 (well-differentiated neuroendocrine tumors (NET G3) and neuroendocrine carcinoma (NEC)) are limited. We retrospectively study patients with NET G3 and NEC from eight European centers. Data examined included clinical and pathological characteristics at diagnosis, therapies and outcomes. Two hundred and four patients were analyzed (...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Digestion
سال: 2017
ISSN: 0012-2823,1421-9867
DOI: 10.1159/000454761